Hartaj Singh
Stock Analyst at Oppenheimer
(0.78)
# 2301
Out of 5,335 analysts
132
Total ratings
38.82%
Success rate
-9.72%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics | Maintains: Outperform | 184 123 | 36.62 | 235.88% | 10 | May 7, 2025 | |
GILD Gilead Sciences | Maintains: Outperform | 132 125 | 102.41 | 22.06% | 14 | Apr 25, 2025 | |
SPRB Spruce Biosciences | Downgrades: Perform | n/a | n/a | n/a | 6 | Dec 11, 2024 | |
ATXS Astria Therapeutics | Maintains: Outperform | 26 28 | 3.91 | 616.11% | 6 | Nov 14, 2024 | |
REGN Regeneron Pharmaceut... | Maintains: Outperform | 1150 1000 | 572.09 | 74.8% | 8 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 575 600 | 307.2 | 95.31% | 7 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 550 540 | 439.55 | 22.85% | 14 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 8 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 11 10 | 1.43 | 599.3% | 5 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 60 | 1.66 | 3514.46% | 5 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 11 | n/a | n/a | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 | 1.9 | 373.68% | 4 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | n/a | n/a | n/a | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 40 | 1.92 | 1983.33% | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 8.64 | 154.63% | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 25 | n/a | n/a | 3 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 16 | n/a | n/a | 3 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 55 | n/a | n/a | 3 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 4 | Jul 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | n/a | n/a | 1 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 30 | n/a | n/a | 3 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 42 | n/a | n/a | 3 | Feb 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 2 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 4 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 650 | 1.45 | 44727.59% | 1 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | n/a | n/a | 1 | Jun 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 30 | 24.74 | 21.26% | 1 | Jan 26, 2018 |